BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8093712)

  • 1. Detection of HTLV-I and HTLV-II infection in Africans using type-specific envelope peptides.
    Goubau P; Desmyter J; Swanson P; Reynders M; Shih J; Surmont I; Kazadi K; Lee H
    J Med Virol; 1993 Jan; 39(1):28-32. PubMed ID: 8093712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human T-cell lymphotropic virus type 1 gag indeterminate western blot patterns in Central Africa: relationship to Plasmodium falciparum infection.
    Mahieux R; Horal P; Mauclère P; Mercereau-Puijalon O; Guillotte M; Meertens L; Murphy E; Gessain A
    J Clin Microbiol; 2000 Nov; 38(11):4049-57. PubMed ID: 11060067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.
    Horal P; Hall WW; Svennerholm B; Lycke J; Jeansson S; Rymo L; Kaplan MH; Vahlne A
    Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5754-8. PubMed ID: 1712105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence and significance of HTLV-I/II seroindeterminate Western blot patterns.
    Abrams A; Akahata Y; Jacobson S
    Viruses; 2011 Aug; 3(8):1320-31. PubMed ID: 21994781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity and specificity of a recombinant transmembrane glycoprotein (rgp21)-spiked western immunoblot for serological confirmation of human T-cell lymphotropic virus type I and type II infections.
    Lal RB; Brodine S; Kazura J; Mbidde-Katonga E; Yanagihara R; Roberts C
    J Clin Microbiol; 1992 Feb; 30(2):296-9. PubMed ID: 1347047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological speciation of human T-cell leukaemia virus infections using synthetic peptide antigens.
    Tosswill JH; McAlpine L; Mortimer PP
    J Med Virol; 1993 May; 40(1):83-5. PubMed ID: 8099946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a p21e-spiked western blot (immunoblot) in confirming human T-cell lymphotropic virus type I or II infection in volunteer blood donors. The Retrovirus Epidemiology Donor Study Group.
    Kleinman SH; Kaplan JE; Khabbaz RF; Calabro MA; Thomson R; Busch M
    J Clin Microbiol; 1994 Mar; 32(3):603-7. PubMed ID: 8195365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of two commercial human T-cell lymphotropic virus western blot (immunoblot) kits with problem specimens.
    Gallo D; Diggs JL; Hanson CV
    J Clin Microbiol; 1994 Sep; 32(9):2046-9. PubMed ID: 7814523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced specificity of truncated transmembrane protein for serologic confirmation of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infections by western blot (immunoblot) assay containing recombinant envelope glycoproteins.
    Varma M; Rudolph DL; Knuchel M; Switzer WM; Hadlock KG; Velligan M; Chan L; Foung SK; Lal RB
    J Clin Microbiol; 1995 Dec; 33(12):3239-44. PubMed ID: 8586709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential antibody responsiveness to p19 gag results in serological discrimination between human T lymphotropic virus type I and type II.
    Lal RB; Brodine SK; Coligan JE; Roberts CR
    J Med Virol; 1991 Dec; 35(4):232-6. PubMed ID: 1687064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Seroprevalence of human T cell lymphotropic virus infection and associated factors of risk in blood donors of Rio Branco city, AC, Brazil (1998-2001)].
    Colin DD; Alcântara Júnior LC; Santos FL; Uchôa R; Tavares-Neto J
    Rev Soc Bras Med Trop; 2003; 36(6):677-83. PubMed ID: 15049106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
    Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB
    Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of serological cross-reactivities with human immunodeficiency virus types 1 and 2 and human T-lymphotropic virus types I and II in sera of pregnant women in Ibadan, Nigeria.
    Olaleye DO; Ekweozor CC; Sheng Z; Rasheed S
    Int J Epidemiol; 1995 Feb; 24(1):198-203. PubMed ID: 7797344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and evaluation of a human T-cell leukemia virus type I serologic confirmatory assay incorporating a recombinant envelope polypeptide.
    Lillehoj EP; Alexander SS; Dubrule CJ; Wiktor S; Adams R; Tai CC; Manns A; Blattner WA
    J Clin Microbiol; 1990 Dec; 28(12):2653-8. PubMed ID: 2279997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified western blot with recombinant antigens for serological differentiation between HTLV-I and HTLV-II.
    Chironna M; Quarto M; Germinario C; Fontana A
    New Microbiol; 1994 Jul; 17(3):177-85. PubMed ID: 7968652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delineation of immunodominant epitopes of human T-lymphotropic virus types I and II and their usefulness in developing serologic assays for detection of antibodies to HTLV-I and HTLV-II.
    Lal RB
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S170-8. PubMed ID: 8797720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of rabbits against HTLV-II infection with a synthetic peptide corresponding to HTLV-II neutralization region.
    Kariya N; Hayashi K; Hoshino H; Tanaka Y; Koirala TR; Ohara N; Miyamoto K; Akagi T
    Arch Virol; 1996; 141(3-4):471-80. PubMed ID: 8645089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.
    Baba E; Nakamura M; Ohkuma K; Kira J; Tanaka Y; Nakano S; Niho Y
    J Immunol; 1995 Jan; 154(1):399-412. PubMed ID: 7527817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HTLV infection in ELISA-negative blood donors.
    Zehender G; Girotto M; De Maddalena C; Francisco G; Moroni M; Galli M
    AIDS Res Hum Retroviruses; 1996 May; 12(8):737-40. PubMed ID: 8744584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
    Blejer JL; Saguier MC; Salamone HJ; Carreras LA
    Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.